228 related articles for article (PubMed ID: 23717698)
1. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis.
Saichua P; Sithithaworn P; Jariwala AR; Diemert DJ; Sithithaworn J; Sripa B; Laha T; Mairiang E; Pairojkul C; Periago MV; Khuntikeo N; Mulvenna J; Bethony JM
PLoS Negl Trop Dis; 2013; 7(5):e2228. PubMed ID: 23717698
[TBL] [Abstract][Full Text] [Related]
2. Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.
Saichua P; Yakovleva A; Kamamia C; Jariwala AR; Sithithaworn J; Sripa B; Brindley PJ; Laha T; Mairiang E; Pairojkul C; Khuntikeo N; Mulvenna J; Sithithaworn P; Bethony JM
PLoS Negl Trop Dis; 2015; 9(7):e0003949. PubMed ID: 26230769
[TBL] [Abstract][Full Text] [Related]
3. Enhanced neutrophil functions during Opisthorchis viverrini infections and correlation with advanced periductal fibrosis.
Salao K; Spofford EM; Price C; Mairiang E; Suttiprapa S; Wright HL; Sripa B; Edwards SW
Int J Parasitol; 2020 Feb; 50(2):145-152. PubMed ID: 32006550
[TBL] [Abstract][Full Text] [Related]
4. Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma.
Pinlaor P; Pongsamart P; Hongsrichan N; Sangka A; Srilunchang T; Mairiang E; Sithithaworn P; Pinlaor S
Parasitol Int; 2012 Mar; 61(1):212-6. PubMed ID: 21718798
[TBL] [Abstract][Full Text] [Related]
5. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis.
Sawangsoda P; Sithithaworn J; Tesana S; Pinlaor S; Boonmars T; Mairiang E; Yongvanit P; Duenngai K; Sithithaworn P
Parasitol Int; 2012 Mar; 61(1):196-202. PubMed ID: 21704727
[TBL] [Abstract][Full Text] [Related]
7. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.
Sripa B; Mairiang E; Thinkhamrop B; Laha T; Kaewkes S; Sithithaworn P; Tessana S; Loukas A; Brindley PJ; Bethony JM
Hepatology; 2009 Oct; 50(4):1273-81. PubMed ID: 19676135
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine.
Worasith C; Kamamia C; Yakovleva A; Duenngai K; Wangboon C; Sithithaworn J; Watwiengkam N; Namwat N; Techasen A; Loilome W; Yongvanit P; Loukas A; Sithithaworn P; Bethony JM
PLoS Negl Trop Dis; 2015; 9(10):e0004157. PubMed ID: 26485024
[TBL] [Abstract][Full Text] [Related]
9. High macrophage activities are associated with advanced periductal fibrosis in chronic Opisthorchis viverrini infection.
Salao K; Watakulsin K; Mairiang E; Suttiprapa S; Tangkawattana S; Edwards SW; Sripa B
Parasite Immunol; 2019 Jan; 41(1):e12603. PubMed ID: 30449026
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic features of hepatobiliary pathology in opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma.
Mairiang E
Parasitol Int; 2017 Aug; 66(4):378-382. PubMed ID: 27956092
[TBL] [Abstract][Full Text] [Related]
11. Association between Opisthorchis viverrini Infection and Glomerular Disease in Thailand.
Tonsawan P; Intarak S; Sripa B; Puapairoj A; Sripa M; Sithithaworn P; Anutrakulchai S
Am J Nephrol; 2022; 53(2-3):199-206. PubMed ID: 35168235
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.
Sripa B; Thinkhamrop B; Mairiang E; Laha T; Kaewkes S; Sithithaworn P; Periago MV; Bhudhisawasdi V; Yonglitthipagon P; Mulvenna J; Brindley PJ; Loukas A; Bethony JM
PLoS Negl Trop Dis; 2012; 6(5):e1654. PubMed ID: 22629477
[TBL] [Abstract][Full Text] [Related]
13. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
[No Abstract] [Full Text] [Related]
14. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
[TBL] [Abstract][Full Text] [Related]
15. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Wangboon C; Yongvanit P; Loilome W; Thanan R; Worasith C; Eamudomkarn C; Chamadol N; Mairiang E; Sithithaworn J; Saichua P; Sripa B; Khuntikeo N; Bethony JM; Sithithaworn P
Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Diagnosis and Detection of Opisthorchis viverrini Sensu Lato in Human and Intermediate Hosts for Use in Control and Elimination Programs.
Saijuntha W; Duenngai K; Tangkawattana S; Petney TN; Andrews RH; Sithithaworn P
Adv Parasitol; 2018; 101():177-214. PubMed ID: 29907254
[TBL] [Abstract][Full Text] [Related]
17.
Haonon O; Liu Z; Dangtakot R; Intuyod K; Pinlaor P; Puapairoj A; Cha'on U; Sengthong C; Pongking T; Onsurathum S; Yingklang M; Phetcharaburanin J; Li JV; Pinlaor S
J Proteome Res; 2021 Aug; 20(8):3940-3951. PubMed ID: 34270897
[No Abstract] [Full Text] [Related]
18. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
Mairiang E; Laha T; Kaewkes S; Loukas A; Bethony J; Brindley PJ; Sripa B
Acta Trop; 2021 May; 217():105853. PubMed ID: 33548204
[TBL] [Abstract][Full Text] [Related]
19. Novel Potential Biomarkers for
Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
[TBL] [Abstract][Full Text] [Related]
20. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
Yongvanit P; Pinlaor S; Loilome W
J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
